David D. Meek - 22 Sep 2021 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Chief Executive Officer, Director
Signature
/s/ Vickie Reed, Attorney-inFact
Issuer symbol
MRTX
Transactions as of
22 Sep 2021
Transactions value $
$0
Form type
4
Filing time
24 Sep 2021, 17:11:07 UTC
Previous filing
24 Sep 2021
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Non Qualified Stock Option (right to buy) Award $0 +150K $0.00 150K 22 Sep 2021 Common Stock 150K $167.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.